AI assistant
BIOXYNE LIMITED — Director's Dealing 2017
May 30, 2017
64594_rns_2017-05-30_3e8fc3cb-cad9-43fd-8645-b95d4f99af59.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Bioxyne Limited ABN 97 084 464 193
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Anthony Ho |
|---|---|
| Date of last notice | 3 February 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct & Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
A.P. & C.H. Ho A/C> |
| Date of change | 30 May 2017 |
| No. of securities held prior to change | Direct 8,900,000 fully paid ordinary shares Indirect 1,190,000 fully paid ordinary shares 1,500,000 options exercisable at 2.34 cents per share expiry24November 2019 |
| Class | Ordinary Shares and Unlisted Options |
| Number acquired | 10,090,000 ordinary shares and 5,045,000 unlisted options with exercise price $0.01 and expiry 15 December 2017. |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$0.01 per share and no consideration for free attaching options |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | Direct 17,800,000 fully paid ordinary shares and 4,450,000 unlisted options exercisable at $0.01 per share expiry 15 December 2017. Indirect 2,380,000 fully paid ordinary shares and 595,000 unlisted options with expiry date 15 December 2017 1,500,000 options exercisable at 2.34 cents per share expiry 24 November 2019 |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Participation in Rights Issue |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder (if issued securities) |
|
| Date of change | |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
|
| Interest acquired | |
| Interest disposed | |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
|
| Interest after change |
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required?
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
|---|---|
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Bioxyne Limited ABN 97 084 464 193
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Patrick Ford |
|---|---|
| Date of last notice | 3 February 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
1. Diskdew Pty Ltd 2. P Ford Superannuation Pty Ltd as trustee for the Patrick Ford Super Fund A/C |
| Date of change | 30 May 2017 |
| No. of securities held prior to change | 1. 1,150,000 fully paid ordinary shares 2. 8,000,000 fully paid ordinary shares 1,250,000 options exercisable at 2.34 cents per share with expiry 24 November 2019 |
| Class | Ordinary shares and Unlisted Options |
| Number acquired | 9,150,000 ordinary shares |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$0.01 per share No consideration for attaching options |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 1. 8,300,000 fully paid ordinary shares and 2,075,000 unlisted option exercise price $0.01 with expiry 15 December 2017 2. 10,000,000 fully paid ordinary shares and 2,500,000 unlisted options exercisable at $0.01 per share expiry 15 December 2017 1,250,000 options exercisable at 2.34 cents per share with expiry 24 November 2019 |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Participation in Rights Issue |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
==> picture [434 x 318] intentionally omitted <==
----- Start of picture text -----
Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change
----- End of picture text -----
Part 3 –[+] Closed period
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002